Asivatrep is a novel, nonsteroidal topical medication classified as an acrylamide derivative, primarily developed for the treatment of atopic dermatitis and various inflammatory skin conditions. The range… Read more
Asivatrep is a novel, nonsteroidal topical medication classified as an acrylamide derivative, primarily developed for the treatment of atopic dermatitis and various inflammatory skin conditions. The range of Asivatrep reference standards includes high-quality API, critical impurities, and degradation products necessary for robust quality control and rigorous pharmaceutical method validation. Laboratories utilize these materials for impurity profiling, ensuring compliance with strict regulatory standards during the development of topical formulations. Additionally, the availability of stable isotope labelled compounds provides an essential tool for accurate quantification in complex matrices, supporting advanced pharmacokinetic studies and supporting the precision of analytical techniques. By offering a comprehensive suite of these analytical standards, this collection enables accurate identification and monitoring of the drug substance and its related compounds throughout the lifecycle of pharmaceutical research and development.